Drug treatment of hyperactivity in children - PubMed (original) (raw)
Clinical Trial
Drug treatment of hyperactivity in children
K J Ottenbacher et al. Dev Med Child Neurol. 1983 Jun.
Abstract
Recently-developed quantitative reviewing procedures were applied to 61 selected studies in order to explore the efficacy of pharmacological management for children identified as hyperactive. Analysis of effect-size information derived from the studies revealed that the average child receiving drug treatment was less hyperactive than 88.5 per cent of the control children. 30 per cent of this effect could be attributed to placebo phenomenon. The analysis also indicated that drug therapy had the most pronounced effect on dependent variables consisting of standardized or informal measures of behaviour and the least effect on measures of IQ and academic achievement. The advantages of quantitative reviewing methodology for adding clarity and consensus to complex bodies of literature are demonstrated and discussed.
Similar articles
- Atypical antipsychotics for disruptive behaviour disorders in children and youths.
Loy JH, Merry SN, Hetrick SE, Stasiak K. Loy JH, et al. Cochrane Database Syst Rev. 2012 Sep 12;(9):CD008559. doi: 10.1002/14651858.CD008559.pub2. Cochrane Database Syst Rev. 2012. PMID: 22972123 Updated. Review. - Methylphenidate and children with attention deficit disorder. Dose effects on classroom academic and social behavior.
Pelham WE, Bender ME, Caddell J, Booth S, Moorer SH. Pelham WE, et al. Arch Gen Psychiatry. 1985 Oct;42(10):948-52. doi: 10.1001/archpsyc.1985.01790330028003. Arch Gen Psychiatry. 1985. PMID: 3899046 Clinical Trial. - A process for developing community consensus regarding the diagnosis and management of attention-deficit/hyperactivity disorder.
Foy JM, Earls MF. Foy JM, et al. Pediatrics. 2005 Jan;115(1):e97-104. doi: 10.1542/peds.2004-0953. Pediatrics. 2005. PMID: 15629972 - Physical activity intervention (Movi-Kids) on improving academic achievement and adiposity in preschoolers with or without attention deficit hyperactivity disorder: study protocol for a randomized controlled trial.
Sánchez-López M, Pardo-Guijarro MJ, Del Campo DG, Silva P, Martínez-Andrés M, Gulías-González R, Díez-Fernández A, Franquelo-Morales P, Martínez-Vizcaíno V; Movi-Kids group. Sánchez-López M, et al. Trials. 2015 Oct 12;16:456. doi: 10.1186/s13063-015-0992-7. Trials. 2015. PMID: 26458986 Free PMC article. Clinical Trial.
Cited by
- Understanding the effects of stimulant medications on cognition in individuals with attention-deficit hyperactivity disorder: a decade of progress.
Swanson J, Baler RD, Volkow ND. Swanson J, et al. Neuropsychopharmacology. 2011 Jan;36(1):207-26. doi: 10.1038/npp.2010.160. Epub 2010 Sep 29. Neuropsychopharmacology. 2011. PMID: 20881946 Free PMC article. Review. - Attention deficit hyperactivity disorder--a review.
Williams C, Wright B, Partridge I. Williams C, et al. Br J Gen Pract. 1999 Jul;49(444):563-71. Br J Gen Pract. 1999. PMID: 10621994 Free PMC article. Review. - Nonmedical use of prescription stimulants among college students: associations with attention-deficit-hyperactivity disorder and polydrug use.
Arria AM, Caldeira KM, O'Grady KE, Vincent KB, Johnson EP, Wish ED. Arria AM, et al. Pharmacotherapy. 2008 Feb;28(2):156-69. doi: 10.1592/phco.28.2.156. Pharmacotherapy. 2008. PMID: 18225963 Free PMC article. - How efficacious and safe is short-acting methylphenidate for the treatment of attention-deficit disorder in children and adolescents? A meta-analysis.
Schachter HM, Pham B, King J, Langford S, Moher D. Schachter HM, et al. CMAJ. 2001 Nov 27;165(11):1475-88. CMAJ. 2001. PMID: 11762571 Free PMC article. - Pharmacokinetic considerations in the treatment of attention-deficit hyperactivity disorder with methylphenidate.
Wolraich ML, Doffing MA. Wolraich ML, et al. CNS Drugs. 2004;18(4):243-50. doi: 10.2165/00023210-200418040-00004. CNS Drugs. 2004. PMID: 15015904 Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical